We show you step-by-step how to make a small business website to help you connect with customers and increase credibility.

Chromolume.io synthesizes the gross weekly box office receipts of Broadway shows to create industry power rankings.

If you want to grow as a web developer, nothing beats hands-on practice. Project-based learning helps you apply HTML, CSS, and JavaScript skills while building a portfolio. From simple UI designs to ...

Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), ...

Minneapolis-based Kraus-Anderson Realty hired Patrick Brama as director of portfolio development. He will focus on the development of KA Realty’s five million square-foot portfolio of commercial ...

Real estate and investment portfolios can add complexity to estate planning. These assets often involve title transfers, valuation issues and tax implications that standard documents may not fully ...

BRD Land & Investment is looking to sell off its multistate real estate development portfolio after filing for Chapter 11 bankruptcy protection. The Charlotte-based land entitlement and permitting ...

Panattoni Development Company has named Tyler Banton as Partner, strengthening the firm’s leadership presence across Southern California’s industrial real estate market. Banton steps into the role ...

In October, SROA announced the final closing of SROA Capital Fund IX, LP ("Fund IX"), which exceeded its $750 million target by raising over $1.15 billion. We believe that this level of interest ...

The first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. DS3790 is a specifically engineered, ...

JOHNSTOWN, COLO. — Uplift Development Group has purchased an 18-property self-storage portfolio in Colorado. The transaction includes 500,000 square feet and more than 3,000 units spanning five cities ...

Daiichi Sankyo’s development of antibody-drug conjugates continues to hit turbulence. Despite the success of Enhertu, the company has experienced two latest hiccups: the discontinuation of internal ...